104 related articles for article (PubMed ID: 9703628)
1. [Certain biochemical features of leukocytes in blast crisis of chronic myelogenous leukemia].
Kharchenko MF; Rybakova LP; Filanovskaia LI; Saltykova LB; Bitiukova ES; Shcherbakova EG; Rukavitsyn OA; Bessmel'tsev SS; Abdulkadyrov KM; Blinov MM
Vopr Med Khim; 1998; 44(3):274-80. PubMed ID: 9703628
[TBL] [Abstract][Full Text] [Related]
2. [Enzymatic markers in chronic myeloleukemia and their importance for identifying a blast crisis].
Filanovskaia LI; Togo AV; Shcherbakova EG; Rogaleva EIu; Blinov MN
Vopr Onkol; 1990; 36(9):1053-8. PubMed ID: 2122593
[TBL] [Abstract][Full Text] [Related]
3. [The importance of studies of the glycosaminoglycans in the peripheral blood leukocytes of patients in the diagnosis of the phases of chronic myeloleukemia].
Kharchenko MF; Bessmel'tsev SS; Rukavitsyn OA; Abdulkadyrov KM; Bitiukova ES; Blinov MN
Ter Arkh; 1997; 69(7):21-6. PubMed ID: 9424753
[TBL] [Abstract][Full Text] [Related]
4. Chronic myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
Mesárosová A; Hrivnáková A; Klobusická M; Babusíková O
Neoplasma; 1995; 42(1):9-14. PubMed ID: 7617076
[TBL] [Abstract][Full Text] [Related]
5. [Thymidine kinase activity in leukocytes from patients with chronic myeloid leukemia at various periods in the disease].
Filanovskaia LI; Togo AV; Shcherbakova EG; Blinov MN
Vopr Med Khim; 1994; 40(1):29-32. PubMed ID: 8122406
[TBL] [Abstract][Full Text] [Related]
6. Lymphoid blast crisis of chronic myelogenous leukemia occurring more than 11 years after receiving an allogeneic bone marrow transplant for chronic myelogenous leukemia in myeloid blast crisis at onset.
Fukuno K; Tsurumi H; Yamada T; Oyama M; Matsuyama T; Terakura S; Kodera Y; Moriwaki H
Bone Marrow Transplant; 2003 Feb; 31(3):211-3. PubMed ID: 12621483
[TBL] [Abstract][Full Text] [Related]
7. Elevated levels of the chromosomal protein HMG 17 in chronic myelogenic leukemia.
Kondos H; Anastasiadou E; Photopoulou A; Cary P; Aleporou-Marinou V; Pataryas T
Biochem Mol Biol Int; 1995 Jul; 36(4):803-9. PubMed ID: 8528142
[TBL] [Abstract][Full Text] [Related]
8. [Changes in serum RNase activities in chronic phase and acute crisis of chronic myelocytic leukemia].
Maruoka K; Yamanaka M; Misago M; Nakata K; Tsukada J; Nagata K; Sato T; Mori N; Oda S; Chiba S
Rinsho Ketsueki; 1989 Jul; 30(7):988-93. PubMed ID: 2810801
[TBL] [Abstract][Full Text] [Related]
9. [Nuclear proteins of human leukocytes in health and in chronic leukemias].
Rybakova LP
Vopr Onkol; 1993; 39(7-12):282-7. PubMed ID: 7825298
[TBL] [Abstract][Full Text] [Related]
10. Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia.
Anand M; Ghara N; Kumar R; Singh S; Sengar M; Panikar N; Raina V; Sharma A
Ann Hematol; 2005 Nov; 84(12):767-70. PubMed ID: 15990995
[TBL] [Abstract][Full Text] [Related]
11. [Nuclear nonhistone proteins in normal and leukemic leukocytes].
Rybakova LP
Vopr Onkol; 1991; 37(7-8):805-12. PubMed ID: 1842633
[TBL] [Abstract][Full Text] [Related]
12. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
13. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
[TBL] [Abstract][Full Text] [Related]
14. Role of immunophenotyping in characterisation of blast crisis of chronic myeloid leukemia--a study of 25 cases.
Padmanabhan V; Varma N; Dash S; Varma S
Indian J Pathol Microbiol; 1996 Jan; 39(1):13-7. PubMed ID: 8755126
[TBL] [Abstract][Full Text] [Related]
15. Chronic myelogenous leukemia showing biphenotypic blast crisis followed by lineage switch to B lymphoblastic leukemia.
Oh SH; Park TS; Kim HR; Lee JY; Kim JH; Shin JH; Lee JN
Leuk Res; 2009 Nov; 33(11):e195-8. PubMed ID: 19446879
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells.
Nimmanapalli R; Fuino L; Bali P; Gasparetto M; Glozak M; Tao J; Moscinski L; Smith C; Wu J; Jove R; Atadja P; Bhalla K
Cancer Res; 2003 Aug; 63(16):5126-35. PubMed ID: 12941844
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of adenosine deaminase isozymes in acute leukemia.
Ratech H; Martiniuk F; Borer WZ; Rappaport H
Blood; 1988 Nov; 72(5):1627-32. PubMed ID: 3140911
[TBL] [Abstract][Full Text] [Related]
18. Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia.
Barnes DJ; Palaiologou D; Panousopoulou E; Schultheis B; Yong AS; Wong A; Pattacini L; Goldman JM; Melo JV
Cancer Res; 2005 Oct; 65(19):8912-9. PubMed ID: 16204063
[TBL] [Abstract][Full Text] [Related]
19. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
20. Mutations of the myeloid transcription factor CEBPA are not associated with the blast crisis of chronic myeloid leukaemia.
Pabst T; Stillner E; Neuberg D; Nimer S; Willman CL; List AF; Melo JV; Tenen DG; Mueller BU
Br J Haematol; 2006 May; 133(4):400-2. PubMed ID: 16643447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
